28 Results

People

  1. Kris
    Kris
  2. Chaft
    Chaft
  3. Riely
    Riely
  4. Yu
    Yu
  5. Drilon
    Drilon
  6. Ni
    Ni
  7. Rudin
    Rudin
  8. Arcila
    Arcila
  9. Hellmann
    Hellmann
  10. Ladanyi
    Ladanyi

Groups

  1. Department of Medicine (28)
  2. Solid Tumor Oncology Division (28)
  3. Thoracic Oncology (28)
  4. GSK Faculty (12)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  6. Sloan Kettering Institute Postdocs (7)
  7. Epidemiology and Biostatistics (6)
  8. Human Oncology and Pathogenesis Program (6)
  9. Biostatistics Service (5)
  10. Surgery (5)
  1. "Mark Kris"
  2. "2017"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (11)
Groups
  1. Department of Medicine (28)
  2. Solid Tumor Oncology Division (28)
  3. Thoracic Oncology (28)
  4. GSK Faculty (12)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  6. Sloan Kettering Institute Postdocs (7)

More Groups

People
  1. Mark Kris (28)
  2. Gregory Riely (7)
  3. Jamie Chaft (7)
  4. Charles Rudin (6)
  5. Helena Yu (6)
  6. Ai Ni (5)

More People

Years
  1. 2017 (28)
Publications
  1. Journal of Clinical Oncology (10)
  2. Journal of Thoracic Oncology (6)
  3. Journal of Oncology Practice (2)
  4. Annals of Behavioral Medicine (1)
  5. Annals of Oncology (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Elsevier Inc. (7)
  3. Nature Publishing Group (2)
  4. American Association for Cancer Research (1)
  5. American Medical Association (1)
  6. Elsevier Ireland Ltd. (1)

More Publishers

Results (28)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Owen, D. H.; Bunn, P. A.; Johnson, B. E.; Kwiatkowski, D. J.; Kris, M. G.; Wistuba, I. I.; Gandhi, M.; Phan, S.; Shames, D. S.; Schulze, K.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • In vitro functional analysis of HER2 variants in lung cancers to evaluate their oncogenic activity and predict clinical response to HER2 targeted therapies
    Meeting Abstract

    Offin, M.; Olah, Z. T.; Sabari, J. K.; Tandon, N.; Feldman, D.; Abou-Alfa, G. K.; Lok, B. H.; Burck, N.; Tarcic, G.; Miron, B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Afatinib in patients with metastatic HER2-mutant lung cancers: An international multicenter study
    Meeting Abstract

    Lai, W. C. V.; Lebas, L.; Milia, J.; Barnes, T. A.; Gautschi, O.; Peters, S.; Ferrara, R.; Ni, A.; Sabari, J. K.; Clarke, S. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing
    Meeting Abstract

    Fan, P. D.; Narzisi, G.; Jayaprakash, A.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Jordan, E.; Wang, L.; Jungbluth, A. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Baseline frequency of brain metastases and outcomes with multikinase inhibitor therapy in patients with RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A. E.; Filleron, T.; Bergagnini, I.; Milia, J.; Hatzoglou, V.; Velcheti, V.; Besse, B.; Mok, T.; Awad, M. M.; Wolf, J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Retrospective analysis of clinical outcomes of early stage ALK-positive (ALK+) non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Dagogo-Jack, I.; Santini, F.; Eng, J.; Yeap, B. Y.; Izar, B.; Chin, E.; Litvak, A.; Jones, D. R.; Kris, M. G.; Shaw, A. T.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Overall survival results of a randomized trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
    Meeting Abstract

    Basch, E. M.; Deal, A. M.; Dueck, A. C.; Bennett, A. V.; Atkinson, T. M.; Scher, H. I.; Kris, M. G.; Hudis, C. A.; Sabbatini, P.; Dulko, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Response to osimertinib following treatment with EGF816 in patients with T790M EGFR mutant NSLCLC
    Meeting Abstract

    Arbour, K. C.; Sequist, L. V.; Piotrowska, Z.; Kris, M. G.; Paik, P. K.; Ni, A.; Plodkowski, A.; Riely, G.; Yu, H. A.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Antiemetics: American Society of Clinical Oncology clinical practice guideline update summary
    Journal Article

    Hesketh, P. J.; Bohlke, K.; Kris, M. G.
    Journal of Oncology Practice (2017)

    Fulltext@MSK | Save
  • A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non small cell lung cancer (NSCLC)
    Meeting Abstract

    Owen, D.; Bunn, P. Jr; Johnson, B.; Kwiatkowski, D.; Kris, M.; Wistuba, I.; Gandhi, M.; Phan, S.; Shames, D.; Schulze, K.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save